IP Library Granted Patent US 7,927,840
Granted Patent B2
US 7,927,840 · App. 11/932,012 · Granted Apr 19, 2011

Method for detecting West Nile Virus nucleic acids in the 3′ non-coding region

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,927,840
App. No.
11/932,012
Granted
Apr 19, 2011
Kind
B2
Abstract

Compositions, methods and kits for detecting flavivirus nucleic acids. Particularly described are methods for detecting West Nile virus nucleic acids in the 3′ non-coding region.

Claims (16)

1. A method of determining the presence of a WNV (West Nile Virus) nucleic acid in a sample, said method comprising the steps of:

(a) synthesizing a double-stranded amplification product in vitro, wherein the double-stranded WNV sequence at one terminus of said double-stranded amplification product is SEQ ID NO: 74 base-paired to the complement thereof; and

(b) determining that said amplification product has formed as an indication of the presence of said WNV nucleic acid in said sample.

2. The method of claim 1 , wherein the synthesizing step comprises synthesizing in an in vitro nucleic acid amplification reaction that comprises reverse transcribing RNA to produce cDNA.

3. The method of claim 1 , wherein the synthesizing step comprises synthesizing in an in vitro nucleic acid amplification reaction that comprises extending with a DNA polymerase each of a pair of primers.

4. The method of claim 1 , wherein the synthesizing step and the determining step are performed in a single reaction vessel.

5. The method of claim 1 , wherein the determining step comprises detecting an optical signal.

6. A method of detecting a WNV (West Nile Virus) nucleic acid sequence synthesized in vitro, comprising the steps of:

(a) synthesizing in an in vitro nucleic acid amplification reaction a double-stranded DNA amplification product; and

(b) detecting with an oligonucleotide probe the WNV nucleic acid sequence in a nucleic acid strand synthesized in the in vitro nucleic acid amplification reaction,

wherein the double-stranded WNV sequence at one terminus of the double-stranded DNA amplification product consists of SEQ ID NO: 74 base-paired to the complement thereof, and

wherein the complement of SEQ ID NO: 74 is a template for enzymatic synthesis of nucleic acid in said in vitro nucleic acid amplification reaction.

7. The method of claim 6 , wherein the in vitro nucleic acid amplification reaction of the synthesizing step comprises a pair of primers.

8. The method of claim 7 , wherein the detecting step comprises detecting the WNV nucleic acid sequence while the in vitro nucleic acid amplification reaction is occurring.

9. The method of claim 8 , wherein the detecting step comprises detecting by fluorimetry.

10. The method of claim 6 , wherein the in vitro nucleic acid amplification reaction in the synthesizing step comprises a reverse transcriptase.

Assignments (7)
SECURITY INTEREST Recorded Apr 8, 2026
From: BIOTHERANOSTICS, INC.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; CYTYC CORPORATION; SUROS SURGICAL SYSTEMS, INC.; GYNESONICS, INC.; BOLDER SURGICAL, LLC; FAXITRON BIOPTICS, LLC; HEALTH BEACONS, INC.; HOLOGIC, INC.
To: ROYAL BANK OF CANADA, AS COLLATERAL AGENT
Reel/Frame 075462/0440 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 035820 FRAME: 0239. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST RELEASE. Recorded Nov 9, 2017
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 044727/0529 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 028810 FRAME: 0745. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY AGREEMENT. Recorded Nov 9, 2017
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 044432/0565 →
SECURITY AGREEMENT Recorded Aug 7, 2015
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; DIRECT RADIOGRAPHY CORP.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 036307/0199 →
SECURITY INTEREST RELEASE REEL/FRAME 028810/0745 Recorded Jun 4, 2015
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 035820/0239 →
SECURITY AGREEMENT Recorded Aug 1, 2012
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 028810/0745 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 2, 2007
From: DEETER, LEE EDGAR; JOHNSON, L URDENIS; LAMBERSON, LISA ANN; MCINTOSH, JOSEPH JAMES; MEROLA, DIANA MARIE; MORENA, ROBERT MICHAEL; RUMSEY, DENNIS FAY
To: CORNING INCORPORATED
Reel/Frame 019198/0634 →